(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS

ST13

US500000086794378

Class

42

Filing

86794378

Registration

5459445

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

10/16/2024

Trademark type

Word

Nice classes

42

Filing date

10/21/2015

Registration date

05/01/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/16/2024

Last transaction

10/16/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2017-11-00

First use in commerce

2017-11-00

Drawing code

4

Owner type

16

Owner location

Blue Bell, PA, US

Examiner

MURRAY, GEORGE WILLIAM

Current location

Historical data usage

Holders and representatives

Holders

Transformative Pharmaceutical Solutions, LLC

Representatives

Susan A. Smith Ballard Spahr LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others; medical monitoring as a part of conducting clinical trials for others; statistical analysis as a part of conducting clinical trials for others; drug logistics as a part of conducting clinical trials for others; maintenance of databases for others; data compilinganalyzing and tracking in the field of clinical trials for research purposes

Publications

History of USPTO decisions and trademark events.

45 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/16/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/16/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/16/2024

E815

TEAS SECTION 8 & 15 RECEIVED

04/17/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/27/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/27/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/27/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/01/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/30/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/29/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/29/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/29/2018

IUAF

USE AMENDMENT FILED

03/13/2018

EISU

TEAS STATEMENT OF USE RECEIVED

03/13/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/28/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/18/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/18/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/03/2017

PUBO

PUBLISHED FOR OPPOSITION

10/03/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/13/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/28/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

08/22/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/16/2017

GNSL

LETTER OF SUSPENSION E-MAILED

02/16/2017

CNSL

SUSPENSION LETTER WRITTEN

02/16/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/08/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/08/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

12/16/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/16/2016

GNSL

LETTER OF SUSPENSION E-MAILED

06/16/2016

CNSL

SUSPENSION LETTER WRITTEN

06/16/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/03/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/03/2016

ALIE

ASSIGNED TO LIE

06/02/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/20/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/19/2016

GNRT

NON-FINAL ACTION E-MAILED

02/19/2016

CNRT

NON-FINAL ACTION WRITTEN

02/19/2016

DOCK

ASSIGNED TO EXAMINER

02/11/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/26/2015

NWAP

NEW APPLICATION ENTERED

10/24/2015

Continuous trademark protection

Get notified about every new filing that threatens TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.